or
forgot password

    • cancer clinical trials in raleigh, NC

    • Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Rex Cancer Center at Rex Hospital

    Trial Locations
    Rex Cancer Center at Rex Hospital
    Cancer Centers of North Carolina - Raleigh
    Prostate Cancer
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    Rex Cancer Center at Rex Hospital
    Raleigh, North Carolina 27607
    Breast Cancer
    Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Raleigh Hematology/Oncology Associates - Wake Practice
    Raleigh, North Carolina 27609
    Lung Cancer
    Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
    Raleigh Hematology/Oncology Associates - Wake Practice
    Raleigh, North Carolina 27609
    Colorectal Cancer
    Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
    Raleigh Hematology/Oncology Associates - Wake Practice
    Raleigh, North Carolina 27609
    Colorectal Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Duke Health Raleigh Hospital
    Raleigh, North Carolina 27609
    Breast Cancer
    Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer
    Raleigh Hematology/Oncology Associates, P.A. - Wake Practice
    Raleigh, North Carolina 27609-7300
    Colorectal Cancer
    Study Comparing GW572016 And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Neoplasms, Breast
    Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy
    Rex Cancer Center at Rex Hospital

    Trial Locations
    Rex Cancer Center at Rex Hospital
    Cancer Centers of North Carolina - Raleigh
    Lung Cancer, Pulmonary Complications, Radiation Fibrosis
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Cancer Centers of North Carolina - Raleigh
    Raleigh, North Carolina 27607
    Breast Cancer
    Study of REN-1654 in Patients With Sciatica Pain
    Wake Research Associates
    Raleigh, North Carolina 27612
    Sciatica, Herniated Disc, Radiculopathy
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Rex Cancer Center

    Trial Locations
    Rex Cancer Center
    Duke Raleigh Hospital
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Rex Cancer Center at Rex Hospital
    Raleigh, North Carolina 27607
    Colorectal Cancer
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Rex Cancer Center at Rex Hospital

    Trial Locations
    Rex Cancer Center at Rex Hospital
    Cancer Centers of North Carolina - Raleigh
    Head and Neck Cancer
    Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Prophylaxis for HPV Infections and Associated Cervical Neoplasia
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Rex Cancer Center

    Trial Locations
    Rex Cancer Center
    Duke Raleigh Hospital
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Environmental Polymorphisms Registry
    Rex UNC Health Care Center
    Raleigh, North Carolina 27607
    Polymorphism
    Combination Of Lapatinib With Carboplatin, Paclitaxel and Trastuzumab In Metastatic Breast Cancer
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Neoplasms, Breast
    Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Neoplasms, Breast
    Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck Cancer
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Neoplasms, Head and Neck, Cancer
    Study To Assess Long Term Safety Of Pazopanib
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Cancer
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    Duke Raleigh Hospital
    Raleigh, North Carolina 27609
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Neoplasms, Head and Neck
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Rex Cancer Center
    Raleigh, North Carolina 27607
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Neoplasms, Prostate, Prostate Cancer
    A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
    Cancer Centers of North Carolina Cancer Centers of NC-Raleigh
    Raleigh, North Carolina 27609
    Myelogenous Leukemia, Chronic
    GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Lung Cancer, Non-Small Cell
    ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Neoplasms, Breast, Breast Cancer
    Adj TC + Herceptin Early Stage Breast Cancer
    Cancer Centers of North Carolina
    Raleigh, North Carolina 27607
    Breast Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    Cancer Centers of North Carolina
    Raleigh, North Carolina 27607
    Breast Cancer
    Docetaxel+Oxali+/-Cetux Met Gastric/GEJ
    Cancer Centers of North Carolina
    Raleigh, North Carolina 27607
    Metastatic Gastric or GEJ Cancer
    Pre-op Rectal ChemoRad +/- Cetuximab
    Cancer Centers of North Carolina
    Raleigh, North Carolina 27607
    Rectal Cancer
    Phase II Sunitinib Prog Met AIPC
    Cancer Centers of North Carolina
    Raleigh, North Carolina 27607
    Metastatic Prostate Cancer
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Rex Cancer Center
    Raleigh, North Carolina 27607
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)
    Cancer Centers of North Carolina
    Raleigh, North Carolina 27607
    Androgen-independent Prostate Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Duke Raleigh Hospital
    Raleigh, North Carolina 27609
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
    Cancer Centers of North Carolina Cancer Centers of NC-Raleigh
    Raleigh, North Carolina 27609
    Myelogenous Leukemia, Chronic
    Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Carcinoma, Renal Cell
    Ofatumumab + Chlorambucil vs Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia
    GSK Investigational Site
    Raleigh, North Carolina 27609
    Leukaemia, Lymphocytic, Chronic
    Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen
    Rex Cancer Center at Rex Hospital
    Raleigh, North Carolina 27607
    Breast Cancer, Menopausal Symptoms
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Rex Cancer Center

    Trial Locations
    Rex Cancer Center
    Duke Raleigh Hospital
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    Cancer Centers of North Carolina - Raleigh

    Trial Locations
    Cancer Centers of North Carolina - Raleigh
    Duke Health Raleigh Hospital
    Endometrial Cancer, Fatigue, Neurotoxicity